IT1394437B1 - Composizione nutraceutica contenente proteine di carne di agnello e/o pollo con batteri probiotici, suo procedimento di preparazione e uso nell'alimentazione umana. - Google Patents

Composizione nutraceutica contenente proteine di carne di agnello e/o pollo con batteri probiotici, suo procedimento di preparazione e uso nell'alimentazione umana.

Info

Publication number
IT1394437B1
IT1394437B1 ITRM2009A000225A ITRM20090225A IT1394437B1 IT 1394437 B1 IT1394437 B1 IT 1394437B1 IT RM2009A000225 A ITRM2009A000225 A IT RM2009A000225A IT RM20090225 A ITRM20090225 A IT RM20090225A IT 1394437 B1 IT1394437 B1 IT 1394437B1
Authority
IT
Italy
Prior art keywords
chicken
procedure
preparation
composition containing
human consumption
Prior art date
Application number
ITRM2009A000225A
Other languages
English (en)
Inventor
Augusto Sannetti
Original Assignee
Farmagens Health Care Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmagens Health Care Srl filed Critical Farmagens Health Care Srl
Priority to ITRM2009A000225A priority Critical patent/IT1394437B1/it
Publication of ITRM20090225A1 publication Critical patent/ITRM20090225A1/it
Application granted granted Critical
Publication of IT1394437B1 publication Critical patent/IT1394437B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
ITRM2009A000225A 2009-05-07 2009-05-07 Composizione nutraceutica contenente proteine di carne di agnello e/o pollo con batteri probiotici, suo procedimento di preparazione e uso nell'alimentazione umana. IT1394437B1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITRM2009A000225A IT1394437B1 (it) 2009-05-07 2009-05-07 Composizione nutraceutica contenente proteine di carne di agnello e/o pollo con batteri probiotici, suo procedimento di preparazione e uso nell'alimentazione umana.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2009A000225A IT1394437B1 (it) 2009-05-07 2009-05-07 Composizione nutraceutica contenente proteine di carne di agnello e/o pollo con batteri probiotici, suo procedimento di preparazione e uso nell'alimentazione umana.

Publications (2)

Publication Number Publication Date
ITRM20090225A1 ITRM20090225A1 (it) 2010-11-08
IT1394437B1 true IT1394437B1 (it) 2012-06-15

Family

ID=41376340

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM2009A000225A IT1394437B1 (it) 2009-05-07 2009-05-07 Composizione nutraceutica contenente proteine di carne di agnello e/o pollo con batteri probiotici, suo procedimento di preparazione e uso nell'alimentazione umana.

Country Status (1)

Country Link
IT (1) IT1394437B1 (it)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61257156A (ja) * 1985-05-09 1986-11-14 Taiyo Fishery Co Ltd コンニヤクの製造方法
WO1988008675A1 (en) * 1987-05-08 1988-11-17 Asahi Denka Kogyo Kabushiki Kaisha Process for preparing pasty proteinous material or proteinous food from crustaceans
US20060115468A1 (en) * 2004-11-26 2006-06-01 Kara Morrison Dietary supplement for treating and preventing gastrointestinal disorders
US20060233915A1 (en) * 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
NL1032840C2 (nl) * 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
CN101248830A (zh) * 2007-09-18 2008-08-27 湖南文理学院 无腥水解蚌肉蛋白功能制品的制备方法

Also Published As

Publication number Publication date
ITRM20090225A1 (it) 2010-11-08

Similar Documents

Publication Publication Date Title
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
BRPI0807132A2 (pt) enzimas para o tratamento de lignocelulósicos, ácidos nucléicos que codificam as mesmas, e metodos e uso das mesmas
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
UA110806C2 (uk) Мікобактеріальна антигенна композиція
BRPI0919193A2 (pt) Uso de lipídeo, e, composição nutricional
IL219876A (en) Antibodies against human 1h-7b or its fragment, preparations containing them and their use in the preparation of drugs
ZA201005768B (en) Composition comprising protein and disperse fat
EA201001223A1 (ru) Стабилизированные белковые композиции
BRPI0919438A2 (pt) mistura de poliésteres, e, uso das misturas de poliésteres
EP2657333A4 (en) PORCINIC CIRCVIRUS TYPE 2, IMMUNE COMPOSITION CONTAINING THE SAME, DOSAGE KIT AND USE THEREOF
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
DK2835059T3 (da) Flydende, enteral ernæringssammensætning med højt proteinindhold
CL2007001488A1 (es) Anticuerpo humano o humanizado anti-integrina alfa5beta1; acido nucleico que lo codifica; vector y celula huesped que lo comprenden; procedimiento de produccion; composicion farmaceutica que lo comprende; y su uso para prevenir o tratar trastornos asociados con la integrina.
PT2291394T (pt) Proteínas de fusão e seus usos no diagnóstico e tratamento de leishmaniose
AP2957A (en) New antibodies specific of the Beta-amyloid peptides and their uses as diagnostic agents or drugs
BRPI0812766A2 (pt) 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas
ITMI20080898A1 (it) Uso di batteri probiotici per il trattamento della iperomocisteinemia
EA201290542A1 (ru) Модифицированные свиные соматотропиновые полипептиды и их применение
CL2011002994A1 (es) Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal.
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
GB2453671B (en) Preparation for use in the treatment of Clostridium difficile and Salmonella
AU316238S (en) Lawning applicator for microbiological cultures
CO6551745A2 (es) Combinación de fármacos con teobromina y su uso en terapia
GB0619816D0 (en) Novel interferon-alpha constructs for use in the treatment of cancer
ITPC20070055A1 (it) Dispositivo autolivellante in particolare per tavoli, sedie o mobili